Ember Hilvers
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 13
- Infection Control in Healthcare 1
- Clostridium difficile and Clostridium perfringens research 1
-
- COVID-19 epidemiological studies 3
- Co-authors
- Malorie Perry (1 shared paper)Ananda Giri Shankar (1 shared paper)Simon L. Cottrell (1 shared paper)Christopher J. Williams (1 shared paper)Catherine Moore (1 shared paper)Mari Morgan (1 shared paper)
- Journals
- Nature (3 papers)Nature Communications (2 papers)Journal of Hospital Infection (2 papers)Scientific Reports (2 papers)Cell (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Ember Hilvers
15 papers receiving 3.4k citations
Ember Hilvers's Hit Papers
Peers
Comparison fields: 5 of 99
- Infectious Diseases 3k
- Modeling and Simulation 198
- Neurology 46
- Genetics 89
- Molecular Biology 147
Countries citing papers authored by Ember Hilvers
This map shows the geographic impact of Ember Hilvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ember Hilvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ember Hilvers more than expected).
Fields of papers citing papers by Ember Hilvers
This network shows the impact of papers produced by Ember Hilvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ember Hilvers. The network helps show where Ember Hilvers may publish in the future.
Co-authors
The 6 scholars most cited alongside Ember Hilvers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | 2020 | 756 | |
| 3 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 4 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 5 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 6 | 2021 | 228 | |
| 7 | 2021 | 72 | |
| 8 | 2022 | 45 | |
| 9 | 2022 | 31 | |
| 10 | 2018 | 19 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 8 | |
| 14 | 2023 | 1 | |
| 15 | 2024 | 1 |
About Ember Hilvers
Ember Hilvers is a scholar working on Infectious Diseases, Modeling and Simulation, Epidemiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 15 papers that have together received 3.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 epidemiological studies (3 papers), Infection Control in Healthcare (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (3k citations), Modeling and Simulation (198 citations), Neurology (46 citations), Genetics (89 citations) and Molecular Biology (147 citations). Ember Hilvers has collaborated with scholars based in United Kingdom. Frequent co-authors include Malorie Perry, Ananda Giri Shankar, Simon L. Cottrell, Christopher J. Williams, Catherine Moore and Mari Morgan. Their work appears in journals such as Nature, Nature Communications, Journal of Hospital Infection, Scientific Reports and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.